[1]李宸 章海燕 徐少华 许海南 张祖宏 龙明智.消融指数指导心房颤动射频消融的有效性和安全性的荟萃分析[J].心血管病学进展,2022,(2):171.[doi:10.16806/j.cnki.issn.1004-3934.2022.02.019]
　LI Chen,ZHANG Haiyan,XU Shaohua,et al.Efficacy and Safety of Radiofrequency Ablation of Atrial Fibrillation Guided by?blation Index: A Meta-Analysis[J].Advances in Cardiovascular Diseases,2022,(2):171.[doi:10.16806/j.cnki.issn.1004-3934.2022.02.019]
点击复制

消融指数指导心房颤动射频消融的有效性和安全性的荟萃分析()
分享到：

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2022年2期
页码:
171
栏目:
论著
出版日期:
2022-02-25

文章信息/Info

Title:
Efficacy and Safety of Radiofrequency Ablation of Atrial Fibrillation Guided by?blation Index: A Meta-Analysis
作者:
李宸1; 2 章海燕2 徐少华2 许海南2 张祖宏1; 2 龙明智 1; 2
(1.南京医科大学研究生院,江苏 南京 211166;2.南京医科大学第二附属医院心血管内科,江苏 南京 210011)
Author(s):
LI Chen1; 2; ZHANG Haiyan2; XU Shaohua2; XU Hainan2; ZHANG Zuhong1; 2; LONG Mingzhi1; 2
(1.Nanjing Medical University Graduate School,Nanjing 211166,Jiangsu,China; 2. Department of Cardiology,The Second Affiliated Hospital of Nanjing Medical University,Nanjing 210011,Jiangsu,China)
关键词:
消融指数; 心房颤动; 射频消融; 荟萃分析
Keywords:
Ablation index; Atrial fibrillation; Radiofrequency ablation; Meta-analysis
DOI:
10.16806/j.cnki.issn.1004-3934.2022.02.019
摘要:
目的 系统评价消融指数指导心房颤动射频消融的有效性和安全性。方法 计算机检索PubMed、Embase、The Cochrane Library、中国期刊全文数据库、万方数据库及维普数据库。搜集有关消融指数指导下行射频消融（试验组）与组织接触压力指导下行射频消融（对照组）的有效性及安全性比较的研究。提取相关数据并按照纽卡斯尔-渥太华量表完成文献质量评价，采用RevMan 5.4和Stata 14.0统计软件进行荟萃分析。结果 共纳入12项研究，共计2 370例受试者。荟萃分析结果显示，试验组的手术时间（MD=﹣12.44，95% CI ﹣21.57~﹣3.30，P=0.008）、透视时间（MD=﹣3.70，95% CI ﹣4.73~﹣2.66，P<0.001）、消融时间（MD=﹣3.40，95% CI ﹣4.93~﹣1.88，P<0.001）相较于对照组均显著减少。试验组的单圈隔离率相较于对照组显著增加（OR=0.41，95% CI 0.32~0.52，P<0.001）。试验组的急性肺静脉电传导恢复风险（OR=0.34，95% CI 0.19~0.60，P<0.001）和术后心房颤动复发风险（OR=0.48，95% CI 0.40~0.59，P<0.001）相较于对照组显著减少。而在手术并发症风险方面，两组比较差异无统计学意义（OR=0.52，95% CI 0.25 ~1.09，P=0.08）。结论 消融指数指导心房颤动射频消融能够显著地减少手术时间、透视时间和消融时间，在提高单圈隔离率的同时，降低了急性肺静脉电传导恢复的风险和术后心房颤动复发风险，并且不会增加手术并发症的发生。
Abstract:
Objective To systematically evaluate the efficacy and safety of ablation index in guiding radiofrequency ablation of atrial fibrillation. Methods Computer searches of PubMed,Embase,the Cochrane Library,the Chinese journal full text database,Wanfang database,and VIP database were performed. Collection of studies about the efficacy and safety comparison between radiofrequency ablation guided by ablation index (trial group) and radiofrequency ablation guided by contact force (control group). Relevant data were extracted and the literature quality evaluation was completed according to the Newcastle-Ottawa Scale. RevMan 5.4 and Stata 14.0 statistical software were adopted for the Meta-analysis. Results 12 studies with 2 370 subjects were included. The results of the Meta-analysis showed that the procedure time (MD=﹣12.44,95% CI ﹣21.57~﹣3.30,P=0.008),fluoroscopy time (MD=﹣3.70,95% CI ﹣4.73~﹣2.66,P<0.001),and ablation time (MD=﹣3.40,95% CI ﹣4.93~﹣1.88,P<0.001) in the trial group were significantly reduced compared with the control group. The rate of isolation after single encirclement in the trial group was significantly increased compared with the control group (OR=0.41,95% CI 0.32~0.52,P<0.001). The risk of recovery of acute pulmonary venous electrical conduction (OR=0.34,95% CI 0.19~0.60,P<0.001) and the risk of postoperative atrial fibrillation recurrence (OR=0.48,95% CI 0.40~0.59,P<0.001) were significantly reduced in the trial group compared with the control group. However,for the risk of procedural complications,there was no significant difference between the two groups (OR=0.52,95% CI 0.25~1.09,P=0.08). Conclusion Radiofrequency ablation guided by ablation index can significantly reduce procedure time,fluoroscopy time,and ablation time while increasing the rate of isolation after single encirclement,reducing the risk of recovery of acute pulmonary venous electrical conduction and postoperative atrial fibrillation recurrence without additional procedural complications

参考文献/References:


[1] Li J,Gao M,Zhang M,et al. Treatment of atrial fibrillation:a comprehensive review and practice guide[J]. Cardiovasc J Afr,2020,31(3):153-158.

[2] Wang Z,Chen Z,Wang X,et al. The disease burden of atrial fibrillation in China from a national cross-sectional survey[J]. Am J Cardiol,2018,122(5):793-798.

[3] 黄从新,张澍,黄德嘉,等. 心房颤动:目前的认识和治疗的建议-2018[J]. 中国心脏起搏与心电生理杂志,2018,32(4):315-368.

[4] January CT,Wann LS,Calkins H,et al. 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation:A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons[J]. Circulation,2019,140(2):e125-e151.

[5] Kirchhof P,Benussi S,Kotecha D,et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS[J]. Eur Heart J,2016,37(38):2893-2962.

[6] Jiang R,Chen M,Fan J,et al. Rationale and study design for ablation of paroxysmal atrial fibrillation guided by ablation index:a multi-center,prospective randomized trial (PAF-AI trial)[J]. J Interv Card Electrophysiol,2021,60(3):439-444.

[7] Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses[J]. Eur J Epidemiol,2010,25(9):603-605.

[8] Liberati A,Altman DG,Tetzlaff J,et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions:explanation and elaboration[J]. BMJ,2009,339:b2700.

[9] Casella M,Dello Russo A,Riva S,et al. An ablation index operator-independent approach to improve efficacy in atrial fibrillation ablation at 24-month follow-up:a single center experience[J]. J Interv Card Electrophysiol,2020,57(2):241-249.

[10] Dhillon G,Ahsan S,Honarbakhsh S,et al. A multicentered evaluation of ablation at higher power guided by ablation index:establishing ablation targets for pulmonary vein isolation[J]. J Cardiovasc Electrophysiol,2019,30(3):357-365.

[11] Hussein A,Das M,Chaturvedi V,et al. Prospective use of ablation index targets improves clinical outcomes following ablation for atrial fibrillation[J]. J Cardiovasc Electrophysiol,2017,28(9):1037-1047.

[12] Kiliszek M,Krzy?anowski K,Wierzbowski R,et al. The value of the ablation index in patients undergoing ablation for atrial fibrillation[J]. Kardiol Pol,2020,78(10):1015-1019.

[13] Lee SR,Choi EK,Lee EJ,et al. Efficacy of the optimal ablation index-targeted strategy for pulmonary vein isolation in patients with atrial fibrillation:the OPTIMUM study results[J]. J Interv Card Electrophysiol,2019,55(2):171-181.

[14] Pedersen JE,Lauritsen KF,Johansen JB,et al. Pulmonary vein isolation using Ablation Index improves outcome in patients with atrial fibrillation[J]. J Atr Fibrillation,2020,12(6):2244.

[15] Phlips T,Taghji P,El Haddad M,et al. Improving procedural and one-year outcome after contact force-guided pulmonary vein isolation:the role of interlesion distance,ablation index,and contact force variability in the ’CLOSE’-protocol[J]. Europace,2018,20(FI_3):f419-f427.

[16] Solimene F,Schillaci V,Shopova G,et al. Safety and efficacy of atrial fibrillation ablation guided by Ablation Index module[J]. J Interv Card Electrophysiol,2019,54(1):9-15.

[17] Yasumoto K,Egami Y,Ukita K,et al. Ablation index guide pulmonary vein isolation can reduce early recurrence of atrial fibrillation:a propensity score-matched analysis[J]. J Interv Card Electrophysiol,2021 Oct 21.DOI:10.1007/s10840-021-01059-y.

[18] 陈丽竹,梁拓,陈小璐,等. 消融指数在射频消融治疗阵发性心房颤动中的作用研究[J]. 临床心血管病杂志,2021,37(3):259-262.

[19] 马彦卓,侯广道,汝磊生,等. 消融指数指导下射频消融术治疗心房颤动的效果研究[J]. 实用心脑肺血管病杂志,2020,28(5):7-11.

[20] 张涛,韩智红,赵华,等. 消融指数指导下阵发性心房颤动射频消融安全和有效性研究[J]. 心肺血管病杂志,2020,39(3):251-254.

[21] Pranata R,Vania R,Huang I. Ablation-index guided versus conventional contact-force guided ablation in pulmonary vein isolation—Systematic review and meta-analysis[J]. Indian Pacing Electrophysiol J,2019,19(4):155-160.

[22] Verma A,Kilicaslan F,Pisano E,et al. Response of atrial fibrillation to pulmonary vein antrum isolation is directly related to resumption and delay of pulmonary vein conduction[J]. Circulation,2005,112(5):627-635.

[23] Tzou WS,Sauer WH. Radiofrequency catheter ablation of?atrial fibrillation:may the force (and stability) be with you,always[J]. JACC Clin Electrophysiol,2020,6(2):153-156.

[24] Virk SA,Bennett RG,Trivic I,et al. Contact force and ablation index[J]. Card Electrophysiol Clin,2019,11(3):473-479.

[25] Chen S,Schmidt B,Bordignon S,et al. Ablation index-guided 50?W ablation for pulmonary vein isolation in patients with atrial fibrillation:procedural data,lesion analysis,and initial results from the FAFA AI High Power Study[J]. J Cardiovasc Electrophysiol,2019,30(12):2724-2731.

[26] Klein LW,Tra Y,Garratt KN,et al. Occupational health hazards of interventional cardiologists in the current decade:results of the 2014 SCAI membership survey[J]. Catheter Cardiovasc Interv,2015,86(5):913-924.

相似文献/References:

[1]贺鹏康,周菁.心房颤动治疗新技术——冷冻球囊消融[J].心血管病学进展,2016,(1):1.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.001]
　HE Pengkang,ZHOU Jing.Cryoballoon Ablation, A Novel Technology for Atrial Fibrillation Treatment[J].Advances in Cardiovascular Diseases,2016,(2):1.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.001]
[2]都明辉,施海峰*,佟佳宾,等.心房颤动消融相关性无症状性脑缺血[J].心血管病学进展,2016,(1):3.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.002]
　DU Minghui,SHI Haifeng*,TONG Jiabin,et al.Silent Cerebral Ischemia Related to Atrial Fibrillation Ablation[J].Advances in Cardiovascular Diseases,2016,(2):3.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.002]
[3]郑环杰,综述,肖骅,等.心房颤动抗栓治疗研究进展[J].心血管病学进展,2016,(2):142.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.012]
　ZHENG Huanjie,XIAO Hua.Progress of Antithrombotic Therapy in Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(2):142.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.012]
[4]张清,综述,罗素新,等.新型Xa 因子抑制剂———依度沙班在心房颤动患者抗凝治疗中的研究进展[J].心血管病学进展,2016,(2):151.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.014]
　ZHANG Qing,LUO Suxin,TANG Jiong.Novel Factor Xa Inhibitors—Edoxaban in Prevention of Stroke in Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(2):151.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.014]
[5]胡红玲,综述,罗素新,等.预防非瓣膜性心房颤动性脑卒中的治疗新进展[J].心血管病学进展,2016,(3):250.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.009]
　HU Hongling,LUO Suxin.New Progress in the Treatment for Cerebral Apoplexy of Nonvalvular Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(2):250.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.009]
[6]王超,杨国澍,综述,等.关附甲素治疗心房颤动的研究进展[J].心血管病学进展,2016,(3):254.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.010]
　WANG Chao,YANG Guoshu,CAI Lin,et al.Research Progress of the Treatment of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(2):254.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.010]
[7]徐小东,综述,杨东辉,等.决奈达隆治疗心房颤动的现状及展望[J].心血管病学进展,2016,(4):368.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.011]
　XU Xiaodong,YANG Donghui.Status and Prospect of Dronedarone in Treating Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(2):368.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.011]
[8]张莎,储国俊,吴弘.经导管左心耳封堵术的临床应用进展[J].心血管病学进展,2015,(5):547.[doi:10.3969/j.issn.1004-3934.2015.05.006]
　ZHANG Sha,CHU Guojun,WU Hong.Clinial Application Advances in Left Atrial Appendage Closure[J].Advances in Cardiovascular Diseases,2015,(2):547.[doi:10.3969/j.issn.1004-3934.2015.05.006]
[9]汪俊,杨浩.心房颤动射频消融的术式演变[J].心血管病学进展,2015,(5):574.[doi:10.3969/j.issn.1004-3934.2015.05.013]
　WANG Jun,YANG Hao.Evolution of Radiofrequency Ablation of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2015,(2):574.[doi:10.3969/j.issn.1004-3934.2015.05.013]
[10]赵璐,苏立.心房颤动与离子通道重构研究进展[J].心血管病学进展,2015,(5):580.[doi:10.3969/j.issn.1004-3934.2015.05.014]
　ZHAO Lu,SU Li.Research Progress of Atrial Fibrillation and Ion Channel Remodeling[J].Advances in Cardiovascular Diseases,2015,(2):580.[doi:10.3969/j.issn.1004-3934.2015.05.014]
[11]孙建英 魏飞宇 范洁.消融指数指导下高功率短时程消融对房颤射频导管消融术后食管损伤的研究进展[J].心血管病学进展,2023,(5):434.[doi:10.16806/j.cnki.issn.1004-3934.2022.05.012]
　SUN Jianying,WEI Feiyu,FAN Jie.High-Power Short-Duration Ablation Guided by Ablation Index for Esophageal Injury After Radiofrequency Ablation of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2023,(2):434.[doi:10.16806/j.cnki.issn.1004-3934.2022.05.012]

更新日期/Last Update: 2022-08-19